Evaxion A EVAX
NASDAQ EVAX
$4.05 +0.72 (+21.62%)
At close: Oct 20, 2026 · 4:00 PM EDT

Evaxion A (EVAX) Receivables - Other (2022 - 2024)

Updated

Evaxion A (EVAX) recorded Receivables - Other of $40,000 in Q2 2025, down 43.7% from $71,000 a year earlier.

Analysis

Evaxion A (EVAX) Receivables - Other (2022 - 2024) Analysis & Trends

At the end of FY2024, Evaxion A reported Receivables - Other of $44,000, up 51.7% from FY2023.

  • Annual Receivables - Other has a four-year compound annual growth rate of -31.0% (FY2020 to FY2024).
  • Across earlier years, Receivables - Other came in at $29,000 in FY2023 (-86.1%), $209,000 in FY2022 (-62.9%), $563,000 in FY2021 (+190.2%) and $194,000 in FY2020.
  • The Q2 2025 figure is the lowest quarterly Receivables - Other since Q4 2023.
  • On a year-over-year basis, Receivables - Other rose in 1 of the last four quarters, with an average decline of 36.2%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Evaxion A 26.27 Mn -39.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 44,000.00
Dec 31, 2023 29,000.00
Jun 30, 2022 117,000.00
Mar 31, 2022 89,000.00
API Access

Evaxion A Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=EVAX&period=max&api_key=YOUR_API_KEY